Stockreport

Verona Pharma reports Q3 results Nov. 04, 2024 2:06 AM ET By: Manshi Mamtora , CFA [Seeking Alpha]

Verona Pharma plc - American Depositary Shares  (VRNA) 
US:NASDAQ Investor Relations: nasdaq.com/symbol/vrna/real-time
PDF Cash and cash equivalents at September 30, 2024 were $336.0 million (December 31, 2023: $271.8 million). More on Verona Pharma Verona Pharma's Ohtuvayre Set To Unlo [Read more]